Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Bensimon

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 10, 2010
Regulatory T cell content in the bone marrow graft does not predict the occurrence of acute GVHDMichelle Rosenzwajg, Nathalie Dhédin, Sébastien Maury, et al.
Lancet (London, England)|December 26, 2008
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyJean-Philippe Collet, Jean-Sébastien Hulot, Anna Pena, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2011
A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliabilityYan Rolland, Marc Vérin, Christine A Payan, et al.
Plos One|August 11, 2011
Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus ScaleChristine A M Payan, François Viallet, Bernhard G Landwehrmeyer, et al.
Plos One|September 23, 2009
Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophyAmmar Al-Chalabi, Alexandra Dürr, Nicholas W Wood, et al.
Ebiomedicine|July 12, 2020
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trialWilliam Camu, Marius Mickunas, Jean-Luc Veyrune, et al.
Annals of the New York Academy of Sciences|May 21, 2024
Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosisHugo Alarcan, Clément Bruno, Patrick Emond, et al.
Journal of Hepatology|September 10, 2022
Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humansTiong Y Lim, Elena Perpiñán, Maria-Carlota Londoño, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2019
Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsyZhongbo Chen, Jason A Chen, Aleksey Shatunov, et al.
Brain Communications|August 19, 2021
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2Ilaria Giovannelli, Nadhim Bayatti, Abigail Brown, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 10, 2010
Regulatory T cell content in the bone marrow graft does not predict the occurrence of acute GVHDMichelle Rosenzwajg, Nathalie Dhédin, Sébastien Maury, et al.
Lancet (London, England)|December 26, 2008
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyJean-Philippe Collet, Jean-Sébastien Hulot, Anna Pena, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2011
A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliabilityYan Rolland, Marc Vérin, Christine A Payan, et al.
Plos One|August 11, 2011
Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus ScaleChristine A M Payan, François Viallet, Bernhard G Landwehrmeyer, et al.
Plos One|September 23, 2009
Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophyAmmar Al-Chalabi, Alexandra Dürr, Nicholas W Wood, et al.
Ebiomedicine|July 12, 2020
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trialWilliam Camu, Marius Mickunas, Jean-Luc Veyrune, et al.
Annals of the New York Academy of Sciences|May 21, 2024
Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosisHugo Alarcan, Clément Bruno, Patrick Emond, et al.
Journal of Hepatology|September 10, 2022
Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humansTiong Y Lim, Elena Perpiñán, Maria-Carlota Londoño, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2019
Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsyZhongbo Chen, Jason A Chen, Aleksey Shatunov, et al.
Brain Communications|August 19, 2021
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2Ilaria Giovannelli, Nadhim Bayatti, Abigail Brown, et al.
Pageof 4